{"result": "(\"entity\"<|>VITAMINA D<|>EVENT<|>Vitamin D is a crucial nutrient that has been studied for its effects on various health conditions, including osteoporosis, cardiovascular diseases, and certain cancers.)\n##\n(\"entity\"<|>INSTITUTO DE MEDICINA NORTEAMERICANO<|>ORGANIZATION<|>The North American Institute of Medicine provides guidelines and recommendations regarding health and nutrition, including vitamin D levels.)\n##\n(\"entity\"<|>ÁCIDO FÓLICO<|>EVENT<|>Folic acid is a vitamin important for human health, particularly in preventing megaloblastic anemia and neural tube defects.)\n##\n(\"entity\"<|>HOMOCISTEÍNA<|>EVENT<|>Homocysteine is a non-protein amino acid that is produced during the metabolism of methionine and is associated with cardiovascular risks.)\n##\n(\"entity\"<|>BISCHOFF-FERRARI<|>PERSON<|>Bischoff-Ferrari is a researcher who conducted a meta-analysis on vitamin D supplementation and its effects on fracture reduction.)\n##\n(\"relationship\"<|>INSTITUTO DE MEDICINA NORTEAMERICANO<|>VITAMINA D<|>The North American Institute of Medicine recommends serum levels of 25-hydroxyvitamin D for health benefits<|>7)\n##\n(\"relationship\"<|>BISCHOFF-FERRARI<|>VITAMINA D<|>Bischoff-Ferrari's meta-analysis suggests that vitamin D supplementation can reduce non-vertebral fractures<|>8)\n##\n(\"relationship\"<|>ÁCIDO FÓLICO<|>HOMOCISTEÍNA<|>Folic acid intake is necessary to convert homocysteine into methionine, thus preventing its accumulation<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ) es suficiente y segura.\n\nNo debemos olvidar la existencia de estudios que demuestran que los modestos beneficios que se consiguen en la prevención de fracturas con la suplementación con calcio y vitamina D deben contrastarse con el aumento del riesgo cardiovascular que producen; además del consabido riesgo de litiasis renal y deterioro de la función renal, así como la interferencia en la absorción de hierro, zinc y otros minerales.\n\n## Vitamina D\n\nEl actual interés por la vitamina D en las últimas décadas nace del descubrimiento de que la mayoría de células y tejidos de nuestro organismo presentan receptores de vitamina D. Varios estudios observacionales sugieren que la vitamina D no solo es efectiva en los adultos para prevenir la osteopenia, la osteoporosis y la osteomalacia, sino que, además, también es efectiva en la prevención de determinados tumores, así como en la prevención de enfermedades cardiovasculares, autoinmunes e infecciosas, mientras que el déficit de esta aumenta los niveles de paratohormona, estimula el sistema renina-angiotensina-aldosterona con tendencia a la hipertensión arterial y a la hipertrofia del ventrículo izquierdo, disminuye la resistencia a la insulina favoreciendo la diabetes y estimula la inflamación sistémica.\n\nLos niveles de vitamina D se determinan midiendo en el suero la 25-hydroxyvitamin D, que se considera el indicador funcional. El Instituto de Medicina Norteamericano recientemente ha recomendado un objetivo de niveles séricos de 25-hydroxyvitamin D de 20 ng/ml (50 nmol/l) (IOM 2011). La prevalencia en el mundo de niveles\n---\nsubóptimos se estima que es alta. Las causas más importantes de deficiencia de vitamina D son la exposición insuficiente al sol, la hiperpigmentación de la piel, el descenso de la ingesta en la dieta, la obesidad y la edad avanzada.\n\nLos resultados sugieren que la vitamina D3 reduce la mortalidad en un 6% (200 participantes a tratar en 2 años para salvar una vida), predominantemente en mujeres mayores institucionalizadas y dependientes para los cuidados. Las demás formas de vitamina D (D2 o ergocalciferol) y las formas activas (alfacalcidol y calcitriol) no mostraron efectos sugestivos sobre la mortalidad.\n\nEn el metaanálisis de Bischoff-Ferrari la suplementación con vitamina D en dosis de 482-770 UI/d reduciría las fracturas no vertebrales en al menos un 20% y las fracturas de cadera en al menos un 18%.\n\nLa Endocrine Society Clinical Practice Guideline sugiere recientemente que las dosis de 1.000 a 2.000 UI de vitamina D3 aumentarían la 25-hydroxyvitamin D al menos hasta 30 ng/ml, claramente por debajo del rango de toxicidad de la vitamina D. En resumen, en las personas mayores se recomienda una ingesta de al menos 15 μg/día, ya que tienen reducida su capacidad de síntesis prácticamente a la mitad.\n\n## Ácido fólico\n\nEl ácido fólico, como el resto de las vitaminas, tiene una gran relevancia en la salud del ser humano. Existen una serie de patologías que guardan especial relación con esta vitamina, destacando la anemia megaloblástica, la prevención de los defectos del tubo neural, la regulación de la homocisteína, prevención del cáncer, función cognitiva y enfermedades neurodegenerativas.\n\nEn las personas de edad avanzada, la carencia de folatos suele manifestarse a través de signos hematológicos y suele asociarse a trastornos en el comportamiento y en la memoria. A veces es la causa de una pseudodemencia o demencia secundaria. En la mayor parte de los casos se debe a una ingesta insuficiente en la dieta.\n\nLa homocisteína es un aminoácido no proteinogénico que se produce en el metabolismo de la metionina. Es citotóxico. El organismo tiene dos vías para evitar su acumulación: su conversión en metionina y su metabolización a cisteína. Para la primera vía se necesita el concurso de los folatos y de la vitamina B12. En la segunda vía se necesita el concurso del piridoxal-fosfato. Los niveles elevados de homocisteína se han identificado como un factor de riesgo independiente para la enfermedad cardiovascular y la enfermedad cerebrovascular. El aumento de la ingesta de folatos disminuye los niveles de homocisteína, actuando como protector vascular.\n\nBasados en los estudios que hay hasta ahora, se precisa una ingesta de al menos 350 μg/día de ácido fólico para mantener \"normal\" la concentración plasmática de homocisteína, y un suplemento de 650 μg/día para reducir las concentraciones altas de\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}